The Question
Every enterprise security team that has adopted Continuous Threat Exposure Management reaches the same frustrating conclusion at roughly the same point: no single vendor covers all of CTEM. The Gartner framework defines five stages — scoping, discovery, prioritization, validation, and mobilization — and when security leaders map their current vendor portfolio against those five stages, there are almost always gaps. The vendors that are strongest in vulnerability management are rarely best-in-class in external attack surface discovery. The platforms built for breach simulation were not designed to anchor an enterprise VM program.
This fragmentation is not a vendor marketing failure. It reflects the genuine technical breadth of what CTEM demands. Discovery requires agent-based scanning, agentless cloud enumeration, and passive EASM across the internet-facing perimeter. Prioritization requires business context, threat intelligence integration, and exploitability modeling. Validation requires active testing against the live environment, not just CVE matching.
The result is a buying decision that is effectively a capability gap analysis first and a vendor selection second. Before any platform evaluation begins, the enterprise needs an honest assessment of which CTEM stage is weakest in its current program.
The CTEM vendor decision is not a single-platform choice — it is a capability gap analysis that identifies which CTEM stage is weakest in your current program and selects the platform that addresses that specific gap.
Why This Matters Now
In early 2025, the MOVEit Transfer and Ivanti Connect Secure exploitation campaigns provided a stark demonstration of what happens when CTEM capability gaps are left unaddressed. In both incidents, the same pattern emerged: vulnerability management programs had identified the CVEs, compliance teams had generated findings, but the validation stage — confirming which systems in the live environment were actually exposed and reachable from the internet — was either absent or too slow.
The CISA reported that Ivanti Connect Secure vulnerabilities (CVE-2025-0282, CVE-2025-0283) were being actively exploited within days of disclosure, affecting government agencies and critical infrastructure operators who had functioning VM programs but lacked external attack surface visibility to determine their actual exposure in real time. The enterprises that fared best had deployed EASM platforms that could answer within hours: "how many of our Ivanti instances are internet-facing, and do any of them have lateral movement paths to sensitive systems?"
That incident crystallized what the vendor landscape conversation is actually about. It is not about which platform has the best dashboard or the most integrations. It is about whether your CTEM program, as composed across whatever vendors you have deployed, can answer the question an attacker has already answered: "which of this organization's exposures are reachable, exploitable, and worth targeting right now?" The 2026 enterprise that cannot answer that question within 24 hours of a major vulnerability disclosure is operating with a material gap.
What the CURVE™ Data Shows
The 2026 Stackcurve CTEM CURVE™ Report evaluated 14 platforms across the CTEM vendor landscape against a standardized capability matrix covering all five CTEM stages. The research found that no single platform achieved Tier 1 ratings across all five stages — a finding that validates the multi-vendor approach most large enterprises have already adopted in practice.
Tenable rated Tier 1 in vulnerability management and prioritization, Tier 2 in EASM, and Tier 3 in validation. Qualys rated Tier 1 in VM and compliance, Tier 2 in prioritization, and Tier 3 in EASM. Palo Alto Xpanse (Cortex) rated Tier 1 in EASM and Tier 2 in prioritization, but does not natively cover the VM or validation stages. Mandiant Attack Surface Management (Google Cloud) rated Tier 1 in threat-intelligence-driven prioritization and Tier 2 in EASM. Pentera rated Tier 1 in validation and Tier 2 in network attack path discovery, but is not a VM or EASM platform.
Among the broader field, XM Cyber rated Tier 1 in attack path analysis and Cymulate rated Tier 1 in BAS-driven validation. CyCognito and Runzero both rated Tier 1 in their respective niches — pure EASM and network asset discovery.
The full vendor rankings are in the 2026 Stackcurve CTEM CURVE™ Report — free to download.
The Gap Most Buyers Miss
Most CTEM buying decisions focus on the platform with the best vulnerability management coverage because VM is where the program started. The gap most enterprises miss is not in VM — it is in the connection between the three functional stages.
Gap 1: Discovery to Prioritization Handoff
The biggest operational failure in most CTEM programs is not that they lack findings — it is that they have too many. A mature Tenable or Qualys deployment in a large enterprise generates millions of vulnerability findings. Without a prioritization layer that incorporates business context (this asset hosts the payment processing service), threat intelligence (this CVE is on the CISA KEV list), and exploitability modeling (this finding is internet-facing with a known working exploit), the VM data becomes noise. Enterprises running VM without prioritization are effectively managing a finding backlog, not a risk program.
Gap 2: Prioritization Without Validation
CVSS scores and even EPSS predictions are theoretical. They describe the potential exploitability of a vulnerability in the abstract. What they cannot tell you is whether a specific compensating control in your environment — a WAF rule, an EDR policy, a network segmentation boundary — actually prevents exploitation. Enterprises that prioritize without validating are at risk of spending remediation budget on findings that are already effectively mitigated, while leaving actually exploitable paths unaddressed.
Gap 3: EASM as an Afterthought
The Palo Alto Xpanse team has published data showing that the average large enterprise has 30–40% more internet-facing assets than its internal asset inventory reflects. Shadow IT, forgotten cloud instances, acquired company infrastructure that was never fully integrated — these assets are not in your VM scope because your VM tool only scans what is registered in CMDB. EASM platforms discover what an attacker discovers: everything with your IP ranges or domain names that is accessible from the internet. Treating EASM as optional in a CTEM program leaves the most attacker-relevant discovery layer absent.
Gap 4: Point-in-Time vs. Continuous
Many enterprises have replaced their annual penetration test with an annual VM scan, declared CTEM adopted, and moved on. CTEM is not a scan — it is a continuous program. The attack surface changes daily as developers deploy new services, cloud configurations drift, and new vulnerabilities are disclosed. The validation that was accurate last quarter may not reflect the environment today. Platforms that support continuous scanning cadences, automated re-validation after remediation, and real-time EASM monitoring address this gap; point-in-time tools do not.
Questions Your Buying Team Should Be Asking
1. Which of the five CTEM stages does this platform natively cover, and which require integrations with third-party tools?
The honest answer to this question should come from the vendor's architecture documentation, not its marketing materials. Ask for a stage-by-stage capability map and confirm whether integrations with your existing security stack (SIEM, SOAR, ITSM) are native and maintained, or rely on community connectors. The integration points between CTEM stages are where programs break operationally.
2. How does the platform handle assets that are not in our CMDB or internal asset inventory?
This question separates EASM-capable platforms from VM tools that require pre-populated asset lists. Any serious CTEM vendor should be able to describe how its platform discovers assets that do not appear in your inventory — and should be able to demonstrate this capability with a proof-of-concept scan against your internet-facing perimeter.
3. How does the platform's prioritization engine incorporate threat intelligence, and specifically does it integrate CISA KEV and EPSS?
CISA KEV integration is table stakes — any enterprise CTEM platform should be pulling this feed and surfacing KEV findings at the top of the remediation queue. EPSS integration is a signal of prioritization maturity. Ask whether the platform allows you to bring your own threat intelligence feeds and how actor-specific TI from commercial providers integrates into the risk score.
4. Does the platform support validation, and if so, what techniques does it use to confirm exploitability in the live environment without disrupting production?
This question exposes the difference between platforms that claim validation capability and those that deliver it. Safe-mode testing, compensating control bypass detection, and production-safe execution are non-negotiable requirements for enterprise validation. Ask for a detailed description of the validation methodology and reference customers who have run validation in production environments similar to yours.
5. What does the mobilization workflow look like — how does a prioritized, validated finding become an assigned, tracked, and verified remediation task?
CTEM programs that fail do not usually fail at discovery or prioritization — they fail at mobilization. If the CTEM platform produces a risk-prioritized, validated finding but there is no automated pathway to create a JIRA ticket, assign it to the responsible team, set SLA expectations, and verify closure, the program stalls at a list. Ask for a live demonstration of the end-to-end mobilization workflow.
The Stackcurve Take
The CTEM vendor landscape in 2026 is best described as a set of strong point solutions in each CTEM stage and a small number of platforms making credible progress toward multi-stage coverage. Tenable and Qualys anchor the VM and prioritization stages for most large enterprises. Palo Alto Xpanse leads in EASM. Pentera leads in network validation. No platform leads across all five stages.
The practical implication for enterprise buyers is that the CTEM program architecture decision comes before the vendor decision. Define your five-stage operating model first — what you are trying to discover, how you will prioritize it, how you will validate exploitability, and how you will drive remediation through operations. Then map that model against your existing vendor portfolio to identify where the capability gaps are. The vendor selection follows from the gap analysis.
For enterprises in the early stages of CTEM adoption, the most common starting point is a Tenable or Qualys VM deployment that is already in place, being extended with an EASM capability (Xpanse or CyCognito) to close the internet-facing asset discovery gap, and a BAS or automated pentesting platform (Pentera or Cymulate) to add the validation stage. That combination addresses the three most common CTEM capability gaps without replacing existing VM investments.
The 2026 Stackcurve CTEM CURVE™ Report covers the full vendor landscape across all five CTEM stages, including detailed capability scorecards, enterprise fit profiles, and pricing benchmarks for each platform. Download it free →
Stackcurve Advisory Briefs are independent research. No vendor pays for placement, tier assignment, or editorial influence. The CURVE™ methodology is disclosed in full at stackcurve.net/research/methodology.